Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances 5. December 2017, section EUDA news
9. June 2026 New health risks for Europeans in a fast-moving drug market People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This...
